World Diabetes Day 2021: A Joint Virtual Issue with Immunology & Cell Biology
Commemorating 100 years since the discovery of insulin
The discovery of insulin 100 years ago heralded a dramatic shift in the treatment of type 1 diabetes (T1D). Until that point, T1D had been a fatal disease with no treatment options, but the discovery of insulin transformed T1D into a chronic disease that could be managed by insulin therapy. To commemorate this discovery on World Diabetes Day, and to celebrate the rich history of T1D research published in the British Society for Immunology (BSI) and Australian and New Zealand Society for Immunology (ASI) journals, we have prepared a joint Virtual Issue highlighting reviews and original research articles on T1D in Immunology & Cell Biology (ASI) and Clinical & Experimental Immunology(BSI). The articles cover a broad range of topics, including the etiology of diabetes, correlates of disease progression and therapeutic approaches. In addition to featuring recent publications, we have also included older topical reviews and original research articles to further highlight the strong history of pioneering research published within our respective journals.
We hope you enjoy reading this collection of articles and we encourage you to share this using the hashtag #WorldDiabetesDay and looping in @CEIjournal and @ImmunolCellBiol.
L. Yeo, I. Pujol-Autonell, R. Baptista, M. Eichmann, D. Kronenberg-Versteeg, S. Heck, G. Dolton, A. K. Sewell, T. Härkönen, M.-L. Mikk, J. Toppari, R. Veijola, M. Knip, J. Ilonen, M. Peakman
I. Buckle, J.D. Loaiza Naranjo, A-S. Bergot, V. Zhang, M. Talekar, R.J. Steptoe, T. Ranjeny, E.E. Hamilton-Williams
Immunology & Cell Biology, 2021
Clinical & Experimental Immunology is an official journal of the British Society for Immunology. Profits derived from the sale of the journal are invested back into the BSI, providing major financial support for the Society's activities. Support the BSI by submitting your work!
